Broach Lifecare Hospital shares made a stellar debut on the BSE SME platform, listing at a 90% premium. The stock opened at Rs 47.5, significantly higher than the IPO issue price of Rs 25, showcasing strong market confidence on its first trading day.
The IPO for Broach Lifecare Hospital witnessed overwhelming demand, with the subscription rate reaching 159.11 times the available shares on the final day of bidding, showing high investor interest in the healthcare provider’s market debut.
Broach Lifecare Hospital Limited operates Maple Hospitals in Bharuch and Ankleshwar, providing top-tier cardiology services including diagnostics, coronary interventions, and pacemaker implantations. Both NABH-certified facilities emphasise luxury, safety, and non-surgical care. Their success stems from affordable, quality services, strategic industrial belt locations, continuous advancement, and a skilled medical team dedicated to patient care.
Broach Lifecare Hospital aims to enhance services by buying a Cath Lab and developing a medical tourism web portal, with additional funds for general corporate purposes and operational enhancements.